Sonoma Pharmaceuticals, Inc. (SNOA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q2 '25: 3.6M Q3 '25: 3.6M Q4 '25: 3.8M Q1 '26: 4M Q2 '26: 5.6M Q3 '26: 4.3M Q4 '26: 5.6M Q1 '27: 6.4M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Gross Profit Quarterly

0 900K 1.8M 2.7M Q2 '25: 1.4M Q3 '25: 1.3M Q4 '25: 1.5M Q1 '26: 1.5M Q2 '26: 2.1M Q3 '26: 1.6M Q4 '26: 2.2M Q1 '27: 2.6M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Income Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q2 '25: -850K Q3 '25: -1M Q4 '25: -656K Q1 '26: -1.1M Q2 '26: -337K Q3 '26: -678K Q4 '26: -351K Q1 '27: -40K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q2 '25: -610K Q3 '25: -928K Q4 '25: -776K Q1 '26: -1.2M Q2 '26: -534K Q3 '26: -819K Q4 '26: -581K Q1 '27: -330K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q2 '25: 2.2M Q3 '25: 2.3M Q4 '25: 2.2M Q1 '26: 2.6M Q2 '26: 3.5M Q3 '26: 2.7M Q4 '26: 3.4M Q1 '27: 3.8M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q2 '25: 354K Q3 '25: 565K Q4 '25: -95K Q1 '26: -2M Q2 '26: -635K Q3 '26: -764K Q4 '26: -519K Q1 '27: -649K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q2 '25: 328K Q3 '25: 563K Q4 '25: -142K Q1 '26: -2.1M Q2 '26: -645K Q3 '26: -811K Q4 '26: -548K Q1 '27: -651K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 1.5M 3M 4.5M Q3 '24: 546K Q1 '25: 851K Q2 '25: 1M Q3 '25: 1.5M Q1 '26: 1.6M Q2 '26: 1.6M Q3 '26: 1.7M Q1 '27: 3.8M Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q2 '25: -6.52 Q3 '25: -5.56 Q4 '25: -2.95 Q1 '26: -2.37 Q2 '26: -2.10 Q3 '26: -1.95 Q4 '26: -1.89 Q1 '27: -1.22 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.